Given the fact that she had multiple vascular risk factors and presented within the thrombolytic window, she was given intravenous TPA.
MEDICATIONS ON ADMISSION:  According to CCC, the family was not aware of her medications:  Albuterol q.i.d., Combivent 2 puffs q.i.d., Diovan 320 mg q.d., Doxycycline 100 mg b.i.d., Duricef 500 mg b.i.d., Flovent 110 mcg 2 puffs b.i.d., Glyburide 10 mg q.a.m., 5 mg q.p.m., Lipitor 10 mg q.d., Metformin 850 mg q.a.m., 1700 mg q.p.m., Zantac 150 mg b.i.d., Rhinocort nasal spray, Aspirin 325 q.d., Naproxen 500 mg b.i.d.
ALLERGIES:  AVANDIA CAUSES SHORTNESS OF BREATH, ACE INHIBITOR UNKNOWN REACTION.
She was therefore given intravenous TPA.
She was therefore started on Heparin with a goal PTT between 45 and 65.
She was very refractory to Heparin and required very large doses in order to maintain this goal.
Antithrombin III was normal.
Homocystine was normal.
Prothrombin gene mutation is pending.
Anticardiolipin antibodies were negative.
Hemoglobin A1C was elevated at 10.6.
Cardiovascular:  Echocardiogram revealed a PFO with an interatrial septal aneurysm as above.
Sugars came under much better control using a single daily dose of Glargine, as well as oral agents.
Heme:  As above in infectious disease, the patient had a urinary tract infection on admission with Klebsiella pneumonia which was treated with Levofloxacin.
Left MCA territory transient ischemic attack status post intravenous TPA.
DISCHARGE MEDICATIONS:  Coumadin dose to be determined, Glargine 20 U q.h.s., Glyburide 10 mg p.o.
q.a.m., 5 mg p.o.
q.p.m., Metformin 500 mg p.o.
b.i.d., Pantoprazole 40 mg p.o.
q.d., Albuterol 1 nebulizer q.6 hours p.r.n.
wheezing, Atorvastatin 10 mg p.o.
q.d., Colace 100 mg p.o.
